Connection
Andrew Kent to Hematologic Neoplasms
This is a "connection" page, showing publications Andrew Kent has written about Hematologic Neoplasms.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.402 |
|
|
|
-
Kent A, Crump LS, Davila E. Beyond aß T cells: NK, iNKT, and ?dT cell biology in leukemic patients and potential for off-the-shelf adoptive cell therapies for AML. Front Immunol. 2023; 14:1202950.
Score: 0.716
-
Kent A, Pollyea DA. Top advances of the year: Leukemia. Cancer. 2023 04 01; 129(7):981-985.
Score: 0.686